Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01859156 · ClinicalTrials.gov registry record

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

A clinical trial, sponsored by Hennepin Healthcare Research Institute.

Completed
Registry status
151
Enrollment target

NCT01859156 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 151 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01859156 has completed, sponsored by Hennepin Healthcare Research Institute.

COMPLETED
Registry status
151 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2006-10
Est. Completion 2014-07

What the Registry Record Tells You About NCT01859156

The ClinicalTrials.gov registry entry for NCT01859156 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01859156 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01859156 about?

NCT01859156 is a clinical study titled "End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning". The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.

What is the current status of trial NCT01859156?

This trial is currently completed. The enrollment target is 151 participants. The study started on 2006-10. Estimated completion is 2014-07.

Who is sponsoring clinical trial NCT01859156?

This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.